Shima Shapoori

Shima Shapoori

Auto-generated profile, based on publicly available information

Shima Shapoori

Department of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Gene
Verified
Journal Article
Closed access
MRMahsa Rezaeepoor
Mahsa Rezaeepoor
SSShima Shapoori
Shima Shapoori
MGMazdak Ganjalikhani-Hakemi
Mazdak Ganjalikhani-Hakemi
MEMasoud Etemadifar
Masoud Etemadifar
FAFereshteh Alsahebfosoul
Fereshteh Alsahebfosoul
MMMarjan Mansourian
Marjan Mansourian

1 January 2019 in Allergologia et Immunopathologia
Verified
Journal Article
Closed access
RYR. Yazdani
R. Yazdani
SSS. Shapoori
S. Shapoori
MRM. Rezaeepoor
M. Rezaeepoor
RSR. Sanaei
R. Sanaei
MGMazdak Ganjalikhani-Hakemi
Mazdak Ganjalikhani-Hakemi
NRNima Rezaei
Nima Rezaei
T helper 9 (TH9) cells are considered as newly classified helper T cells that have an important role in the regulation of immune responses. Since these cells preferentially produce IL-9, these cells are termed TH9 cells. Recently, the role of TH9 and its signature cytokine (IL-9) has been investigated in a wide range of diseases, including autoimmunity, allergy, infections, cancer and immunodeficiency. Herein, we review the most recent data concerning TH9 cells and IL-9 as well as their roles in disease. These insights suggest that TH9 cells are a future target for therapeutic intervention.

1 February 2020 in Cytokine
Verified
Journal Article
Closed access
AGAli Ganji
Ali Ganji
MMMohsen Ebrahimi Monfared
Mohsen Ebrahimi Monfared
SSShima Shapoori
Shima Shapoori
PNParisa Nourbakhsh
Parisa Nourbakhsh
AGAli Ghazavi
Ali Ghazavi
GMGhasem Mosayebi
Ghasem Mosayebi

1 March 2018
Verified
Journal Article
Open access
PDF file
MRMahsa Rezaeepoor
Mahsa Rezaeepoor
MGMazdak Ganjalikhani-Hakemi
Mazdak Ganjalikhani-Hakemi
SSShima Shapoori
Shima Shapoori
NENahid Eskandari
Nahid Eskandari
MSMohammadreza Sharifi
Mohammadreza Sharifi
MMMarjan Mansourian
Marjan Mansourian
Objective: Semaphorin-3A (SEMA3A) and its receptors are found on some immune cells and act as suppressors of immune cells over-activation. Considering the role of SEMA3A and its down-regulation in some autoimmune diseases, as well as our bioinformatics predictions, we assumed that miR-145-5p might affect SEMA3A expression. So, we aimed to determine the effect of miR-145-5p on SEMA3A gene expression level. Materials and Methods: In this experimental study, we evaluated the effect of miR-145-5p transfection on SEMA3A expression in peripheral blood mononuclear cells (PBMCs) using ELISA and quantitative real-time polymerase chain reaction (PCR) methods. Results: Our results showed that miR-145-5p is able to decrease SEMA3A expression at both protein and mRNA levels. These data confirmed our previous bioinformatic prediction about the inhibitory effect of miR-145-5p on SEMA3A expression. Conclusion: These results enlightened us about an unknown aspect of SEMA3A role in some autoimmune disorders like multiple sclerosis (MS) and rheumatoid arthritis (RA) and also proposed SEMA3A as a potential therapeutic approach.

4 June 2020 in Neurological Research
Verified
Journal Article
Closed access
SSShima Shapoori
Shima Shapoori
GMGhasem Mosayebi
Ghasem Mosayebi
MMMohsen Ebrahimi Monfared
Mohsen Ebrahimi Monfared
AGAli Ghazavi
Ali Ghazavi
BKBehzad Khansarinejad
Behzad Khansarinejad
AGAli Ganji
Ali Ganji
Recently, members of the semaphorin family have received major attention in various medical fields, especially autoimmunity. In this study, we selected semaphorin-3A (Sema3A), semaphorin-7A (Sema7A...

1 January 2019
Verified
Journal Article
Closed access
MAMahmoud Amini
Mahmoud Amini
APAbdolali Pakdaman
Abdolali Pakdaman
SSShima Shapoori
Shima Shapoori
GMGhasem Mosayebi
Ghasem Mosayebi